Distinguished neurologist, Clinical Professor David Blacker AM, recognised nationally for his clinical and research achievements, has retired as Medical Director of Western Australia’s Perron Institute.
“Clinical Professor Blacker is an inspiring role model, renowned for his dedication to improving the lives of people suffering from neurological conditions,” said Steve Arnott, Perron Institute Chief Executive Officer.
“The Institute has been fortunate to have had the services of this esteemed Australian clinician and research leader as our Medical Director for more than a decade.
“Working with multidisciplinary teams in clinical neurology, particularly stroke and Parkinson’s disease, Clinical Professor Blacker has made an outstanding contribution.
“His passion for driving discovery in neurological diseases and improving patient care through a translational focus has contributed greatly to the Perron Institute’s growth and achievements as one of Australia’s leading research institutes in this field.”
Clinical Professor Blacker was diagnosed with Parkinson’s several years ago. His collaboration with boxing trainer Rai Fazio, a former Golden Gloves champion, to undertake the FIGHT-PD study led to an ongoing program for people with this neurodegenerative condition.
“Another highlight of my time at the Perron Institute has been my involvement with developing neuroprotective peptide ARG-007 for stroke and other conditions led by Professors Bruno Meloni and Neville Knuckey,” Clinical Professor Blacker said.
“This is now at an advanced stage, being evaluated in a Phase 2 clinical trial led by Argenica Therapeutics.”
Taking on the leadership role of Medical Director is Professor Merrilee Needham, consultant neurologist and Head of Myositis Research at the Perron Institute and the Personalised Medicine Centre at Murdoch University, and Foundation Chair of Neurology and Consultant Neurologist at Fiona Stanley Hospital.
“Professor Needham is perfectly positioned to take on the role, and oversee the start of an exciting new era,” Clinical Professor Blacker said.
“Four young neurologists will commence work at the Perron Institute through 2025, heralding a time of refreshment and renewal. All of them are bringing back new knowledge and connections after time spent doing fellowships overseas or interstate.”
Clinical Professor Blacker will remain at the Perron Institute, taking on the role of Research Advisor and maintaining his Newly Diagnosed Parkinson’s Clinic, delivered in partnership with Parkinson’s WA, at the Perron Institute.